Christina '. Hart

Franz Josef Strauss Allee 11
Regensburg, BY 93042, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 54 publications

Coagulation Disorders in Philadelphia Chromosome-negative Myeloproliferative Neoplasms-A Guide for Specialists in Coagulation Disorders.

Coagulation Disorders in Philadelphia Chromosome-negative Myeloproliferative Neoplasms-A Guide for Specialists in Coagulation Disorders.

Journal: Hamostaseologie

Published: June 11, 2026

Plasma lipid alterations in thrombosis and antiphospholipid syndrome - a differentiating lipid plasma composite score.

Plasma lipid alterations in thrombosis and antiphospholipid syndrome - a differentiating lipid plasma composite score.

Journal: Journal of lipid research

Published: April 02, 2026

Thrombophilia Testing in Women and Adolescent Girls-Position Paper from the Standing Committee on Women's Health Issues of the Society for Thrombosis and Haemostasis Research (GTH).

Thrombophilia Testing in Women and Adolescent Girls-Position Paper from the Standing Committee on Women's Health Issues of the Society for Thrombosis and Haemostasis Research (GTH).

Journal: Hamostaseologie

Published: February 12, 2026

Management of Breakthrough Bleeding During Emicizumab Prophylaxis in Acquired Haemophilia A: Data From the GTH-AHA-EMI Study.

Management of Breakthrough Bleeding During Emicizumab Prophylaxis in Acquired Haemophilia A: Data From the GTH-AHA-EMI Study.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: January 20, 2026

Excessive Apixaban Concentrations in a Bleeding Patient Treated With Pharmacological Reversal and Extracorporal Removal-A Case Report.

Excessive Apixaban Concentrations in a Bleeding Patient Treated With Pharmacological Reversal and Extracorporal Removal-A Case Report.

Journal: Pharmacology research & perspectives

Published: October 23, 2025

Revisiting clinical response and refractoriness in immune thrombotic thrombocytopenic purpura.

Revisiting clinical response and refractoriness in immune thrombotic thrombocytopenic purpura.

Journal: Blood

Published: October 14, 2025

Revisiting Clinical Response and Refractoriness in Immune Thrombotic Thrombocytopenic Purpura.

Revisiting Clinical Response and Refractoriness in Immune Thrombotic Thrombocytopenic Purpura.

Journal: Blood

Published: October 14, 2025

Five-Year Experience of Haemophilia Centre Certification Performed by the German, Austrian and Swiss Society for Thrombosis and Haemostasis Research.

Five-Year Experience of Haemophilia Centre Certification Performed by the German, Austrian and Swiss Society for Thrombosis and Haemostasis Research.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: August 13, 2025

Implications of the API-CAT Trial for Extended Secondary Prophylaxis of Cancer-associated Venous Thromboembolism: Guidance from an Expert Panel.

Implications of the API-CAT Trial for Extended Secondary Prophylaxis of Cancer-associated Venous Thromboembolism: Guidance from an Expert Panel.

Journal: Hamostaseologie

Published: August 07, 2025

Sustained survival benefit of emicizumab and postponed immunosuppression in acquired hemophilia A.

Sustained survival benefit of emicizumab and postponed immunosuppression in acquired hemophilia A.

Journal: Blood advances

Published: May 13, 2025

Disorders of Thrombosis and Hemostasis in Cancer.

Disorders of Thrombosis and Hemostasis in Cancer.

Journal: Hamostaseologie

Published: May 07, 2025

Thrombin generation to predict breakthrough bleeding in patients with acquired hemophilia A under emicizumab prophylaxis.

Thrombin generation to predict breakthrough bleeding in patients with acquired hemophilia A under emicizumab prophylaxis.

Journal: Haematologica

Published: April 24, 2025

Showing 1-12 of 54

Last Updated: 09/26/2026